ClinicalTrials.Veeva

Menu

Prostaglandin F2alpha in a Human Headache Model

D

Danish Headache Center

Status

Completed

Conditions

Headache

Treatments

Drug: Isoton sodium chloride
Drug: Prostaglandin F2alpha

Study type

Interventional

Funder types

Other

Identifiers

NCT01327118
DHC-PGF2-2010

Details and patient eligibility

About

The hypothesis of this study is that PGF2alpha does not induce headache or dilatation of brain vessels.

Enrollment

12 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy volunteers

Exclusion criteria

  • Primary Headache
  • Headache on the day of the investigation
  • Hypertension
  • Hypotension
  • Pregnant/nursing
  • Daily intake of medication (except oral contraceptives)
  • Cardiovascular or central nervous system (CNS) disease
  • Drug/alcohol abuse
  • Psychiatric disease

Trial design

12 participants in 2 patient groups, including a placebo group

Isoton sodium chloride
Placebo Comparator group
Treatment:
Drug: Isoton sodium chloride
Prostaglandin F2alpha
Active Comparator group
Treatment:
Drug: Prostaglandin F2alpha

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems